Tamer Khayal, M.D.

Tamer Khayal, M.D.

Former Chief Commercial OfficeratTransMedics Group· In proxies 2021–2025

Pay in FY2025+22% from the year before · TransMedics Group stock +95.1% the same year

Tamer Khayal, M.D. was paid $3.8M in FY2025 (Dec), up 22%. TransMedics Group stock rose 95.1% that year.

Pay$100 in the stock at the end of FY20 → $611
Pay is from the Summary Compensation Table of each TransMedics Group proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. TransMedics GroupPublic company · 5 yr
    • Former Chief Commercial Officer2021 – Present · 5 yrStock in role +256%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?